1. Influence of Diabetes Mellitus on Clinical Outcomes Following Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction 
Lisette Okkels Jensen, MD, PhD, Michael Maeng, MD, PhD, Per Thayssen, MD, DMSci, Hans Henrik Tilsted, MD, Christian Juhl Terkelsen, MD, PhD, Anne Kaltoft, MD, PhD, PhD, Jens Flensted Lassen, MD, PhD, Knud Nørregaard Hansen, MD, Jan Ravkilde, MD, DMSci, Evald Høj Christiansen, MD, PhD, Morten Madsen, MSc, Henrik Toft Sørensen, MD, PhD, DMSci, Leif Thuesen, MD, DMSci 
American Journal of Cardiology 
Volume 109, Issue 5, Pages (March 2012)
DOI: /j.amjcard
Copyright © 2012 Elsevier Inc. Terms and Conditions

2. Figure 1
(A) Risk of definite stent thrombosis, (B) risk of definite, probable, and possible stent thrombosis, (C) risk of myocardial infarction, (D) target lesion revascularization, (E) all-cause mortality, and (F) cardiac mortality in patients with ST-segment elevation myocardial infarction with and without diabetes mellitus treated with primary percutaneous coronary intervention (unadjusted data).
American Journal of Cardiology  , DOI: ( /j.amjcard )
Copyright © 2012 Elsevier Inc. Terms and Conditions